• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

    1/16/24 7:52:31 AM ET
    $AGEN
    $AULT
    $AUVI
    $BCEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Machinery/Components
    Technology
    Get the next $AGEN alert in real time by email

    Shares of LQR House Inc. (NASDAQ:LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House.

    LQR House shares jumped 16.1% to $4.25 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Rail Vision Ltd. (NASDAQ:RVSN) shares rose 64% to $2.28 in pre-market trading after gaining over 13% on Friday.
    • Phunware, Inc. (NASDAQ:PHUN) shares jumped 34.5% to $0.1021 in pre-market trading.
    • MorphoSys AG (NASDAQ:MOR) gained 18.8% to $10.21 in pre-market trading.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares climbed 13.6% to $1.17 in pre-market trading after falling more than 6% on Friday.
    • U Power Limited (NASDAQ:UCAR) shares gained 12.7% to $0.1459 in pre-market trading.
    • WISeKey International Holding AG (NASDAQ:WKEY) gained 11.8% to $2.87 in pre-market trading. SEALSQ launched SEALCOIN.AI in partnership with Google Cloud.
    • Agenus Inc. (NASDAQ:AGEN) surged 10.8% to $0.7089 in pre-market trading after falling 10% on Friday.
    • MGO Global, Inc. (NASDAQ:MGOL) gained 9.1% to $0.7801 in pre-market trading after falling around 18% on Friday.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) surged 8.3% to $18.76 in pre-market trading.

    Losers

    • Ault Alliance, Inc. (NYSE:AULT) shares fell 26.1% to $0.0510 in pre-market trading after declining around 3% on Friday.
    • SRIVARU Holding Limited (NASDAQ:SVMH) shares declined 23.3% to $0.2510 in pre-market trading after surging 46% on Friday.
    • Atreca, Inc. (NASDAQ:BCEL) shares fell 18.4% to $0.2908 in pre-market trading after jumping around 53% on Friday.
    • Charge Enterprises, Inc. (NASDAQ:CRGE) shares fell 16.3% to $0.19 in pre-market trading after jumping around 180% on Friday.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 15.4% to $0.4316 in pre-market trading after declining 7% on Friday.
    • Tarena International, Inc. (NASDAQ:TCTM) fell 12.4% to $1.03 in pre-market trading after declining around 8% on Friday.
    • Applied UV, Inc. (NASDAQ:AUVI) shares declined 12.1% to $3.35 in pre-market trading. Applied UV shares jumped 67% on Friday after the company announced the launch of its Fighter Flex LED solution at the upcoming AHR Expo on January 22nd.
    • Inpixon (NASDAQ:INPX) shares fell 9.3% to $0.0438 in pre-market trading. Inpixon shares gained 8% on Friday after the company provided an update on pending strategic transactions.
    • XPeng Inc. (NYSE:XPEV) fell 6.3% to $11.03 in pre-market trading. XPeng AeroHT, which is planning an electric vertical takeoff and landing— or eVTOL — flying car and a modular flying car, showed off the former at the Consumer Electronics Show 2024.
    • Wipro Limited (NYSE:WIT) fell 6.1% to $5.90 in pre-market trading. Wipro shares gained 17% on Friday after the company reported third-quarter financial results, issued guidance and declared an interim dividend.


    Now Read This: Goldman Sachs, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AGEN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGEN
    $AULT
    $AUVI
    $BCEL

    CompanyDatePrice TargetRatingAnalyst
    XPeng Inc.
    $XPEV
    3/23/2026$19.00Outperform → Neutral
    Macquarie
    XPeng Inc.
    $XPEV
    11/18/2025$29.00Neutral → Buy
    Daiwa Securities
    Wipro Limited
    $WIT
    10/20/2025Outperform → Hold
    CLSA
    XPeng Inc.
    $XPEV
    8/18/2025$19.00Neutral
    BNP Paribas Exane
    Wipro Limited
    $WIT
    6/20/2025Underweight → Equal-Weight
    Morgan Stanley
    XPeng Inc.
    $XPEV
    6/17/2025$16.39 → $24.00Neutral → Buy
    Goldman
    Agenus Inc.
    $AGEN
    6/4/2025$25.00Neutral → Buy
    H.C. Wainwright
    XPeng Inc.
    $XPEV
    5/21/2025Neutral → Outperform
    Macquarie
    More analyst ratings

    $AGEN
    $AULT
    $AUVI
    $BCEL
    SEC Filings

    View All

    SEC Form 6-K filed by U Power Limited

    6-K - U Power Ltd (0001939780) (Filer)

    4/7/26 4:30:13 PM ET
    $UCAR
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form SCHEDULE 13D filed by Phunware Inc.

    SCHEDULE 13D - Phunware, Inc. (0001665300) (Subject)

    4/6/26 6:07:55 PM ET
    $PHUN
    EDP Services
    Technology

    SEC Form 6-K filed by Wipro Limited

    6-K - WIPRO LTD (0001123799) (Filer)

    4/6/26 4:01:02 PM ET
    $WIT
    EDP Services
    Technology

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Armen Garo H

    4 - AGENUS INC (0001098972) (Issuer)

    4/6/26 4:15:05 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Olive Christopher D.

    4 - Phunware, Inc. (0001665300) (Issuer)

    4/3/26 9:30:05 PM ET
    $PHUN
    EDP Services
    Technology

    SEC Form 4 filed by Wang Fengying

    4 - XPENG INC. (0001810997) (Issuer)

    4/3/26 7:20:07 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U Power Limited Signs $3.19 Million Subscription Agreements with Strategic Investors

    SHANGHAI, April 7, 2026 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a provider of AI-integrated solutions for next-generation energy grids and intelligent transportation systems, today announced that on April 7, 2026, it entered into subscription agreements (the "Subscription Agreements") with seven purchasers, for the sale of 2,900,000 Class A Ordinary Shares (each, a "Share" and collectively, the "Shares") of the Company at $1.10 per Share (the "Transaction"). Gross proceeds to the Company from this Transaction will be $3,190,000. The closing of the Transaction contemplated hereby is expected to take place on or about April 7, 2026, and has been approved by

    4/7/26 6:37:00 PM ET
    $UCAR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026

    Study highlights novel multi-mechanistic immunotherapy combination in checkpoint-refractory disease Data expected to inform immune modulation, treatment sequencing, and durability of response across hard-to-treat tumors Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that data from an investigator-initiated Phase II trial conducted at Memorial Sloan Kettering Cancer Center will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026, in San Diego, CA. The study evaluates botensilimab (BOT) and balstilimab (BAL) in combination with agenT-797, an allogeneic iNKT cell therapy developed by MiN

    4/3/26 7:30:00 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    U POWER LIMITED Makes Major Breakthrough in Thailand's Heavy-Duty Truck Battery-Swapping Market

    Hong Kong Taxi Battery-Swapping Operations Expected to Launch SoonSHANGHAI, April 2, 2026 /PRNewswire/ -- U POWER Limited, a provider of specialized solutions for next-generation energy networks and intelligent transportation systems, announced that, following its securing an order for 1,000 battery-swapping heavy-duty trucks in Thailand and completing production of the first batch of vehicles, its Hong Kong taxi battery-swapping project is also expected to complete station deployment and commence operations in the second quarter of 2026. This development marks a new stage of full commercial rollout for U POWER LIMITED's battery-swapping business for commercial vehicles across the Asian mark

    4/2/26 7:00:00 AM ET
    $UCAR
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hoffman Alexandra bought $8,125 worth of shares (8,000 units at $1.02), increasing direct ownership by 959% to 8,834 units (SEC Form 4)

    4 - LQR House Inc. (0001843165) (Issuer)

    12/2/24 9:00:52 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    CHIEF EXECUTIVE OFFICER Dollinger Sean bought $29,951 worth of shares (28,700 units at $1.04), increasing direct ownership by 59% to 77,243 units (SEC Form 4)

    4 - LQR House Inc. (0001843165) (Issuer)

    11/26/24 4:16:58 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    Executive Chairman Ault Milton C Iii bought $4,798 worth of shares (22,500 units at $0.21) and bought $82 worth of 13% Series D Cumulative Redeemable Perpetual Preferred Stock (6 units at $13.69), increasing direct ownership by 5% to 116 units (SEC Form 4)

    4 - Ault Alliance, Inc. (0000896493) (Issuer)

    9/12/24 6:00:06 PM ET
    $AULT
    Industrial Machinery/Components
    Technology

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    XPeng downgraded by Macquarie with a new price target

    Macquarie downgraded XPeng from Outperform to Neutral and set a new price target of $19.00

    3/23/26 8:28:29 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    XPeng upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded XPeng from Neutral to Buy and set a new price target of $29.00

    11/18/25 8:16:49 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    Wipro downgraded by CLSA

    CLSA downgraded Wipro from Outperform to Hold

    10/20/25 8:54:57 AM ET
    $WIT
    EDP Services
    Technology

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Leadership Updates

    Live Leadership Updates

    View All

    SEALSQ Signs Letter of Intent to Acquire 100% of Miraex, a Swiss Quantum Interconnect Platform Company

    Geneva, Switzerland, March 24, 2026 (GLOBE NEWSWIRE) -- Strategic Acquisition via the SEALSQ Quantum Fund Strengthens its Quantum Vertical Stack SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or the "Company"), a subsidiary of WISeKey International Holding Ltd (NASDAQ:WKEY, SIX: WIHN)) and a leader in post-quantum semiconductor and cybersecurity solutions, today announced that it has signed a Letter of Intent ("LOI") to acquire 100% of the equity interest of Miraex SA ("Miraex"), a developer of photonics-based quantum interconnect solutions that bridge quantum processors and quantum networks, headquartered at the EPFL Innovation Park in Ecublens, Switzerland. The LOI provides for a 60-day exclusivi

    3/24/26 9:20:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    WISeKey and Partners Present the Human-AI-T Manifesto to at Davos 2026 during the WISeKey Event

    WISeKey and Partners Present the Human-AI-T Manifesto at Davos 2026 during the WISeKey Event Ensuring Human Control, Trust, and Values in the Age of AGI and Quantum Computing For more information visit: https://www.wisekey.com/embedding-human-values-into-ai/ Davos, Switzerland, January 19, 2026 – WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that in collaborations with its partners, gathered at the WISeKey Davos Event, will formally present the Human-AI-T (Human – Artificial Intelligence – Trust) Manifesto, a global framework designed to safeguard human sovereignty, trust, and ethical g

    1/19/26 1:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Financials

    Live finance-specific insights

    View All

    Rail Vision Announces Second Half and Full Year 2025 Financial Results

    Company presents strong balance sheet with year-end cash of approximately $20 million and zero debt Revenue up 14.4% year-over-year Ra'anana, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN, FSE: C80)) ("Rail Vision" or the "Company"), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, today announced its financial results for the second half and full year ended December 31, 2025. The Company reported revenue growth and operational progress, strengthening its global market presence. "2025 was a transformative year for Rail Vision," said David BenDavid, Chief Executive Officer. "We advan

    3/31/26 4:02:00 PM ET
    $RVSN
    Railroads
    Industrials

    XPENG Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

    The Company achieved a positive net profit of RMB0.38 billion in the fourth quarter of 2025, recorded a positive net profit for a single quarter for the first time.Cash position[i] was RMB47.66 billion (US$6.81 billion) as of December 31, 2025Quarterly total revenues were RMB22.25 billion, a 38.2% increase year-over-yearQuarterly gross margin was 21.3%, an increase of 6.9 percentage points over the same period of 2024Quarterly vehicle margin was 13.0%, an increase of 3.0 percentage points over the same period of 2024Full year vehicle deliveries reached 429,445, a 125.9% increase year-over-yearFull year revenues reached RMB76.72 billion, an 87.7% increase year-over-yearFull year gross margin

    3/20/26 5:00:00 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

    Early access programs expand globally: 200+ physician inquiries across 30+ countries; $4.2M in initial program revenue recognized CRC leads BOT+BAL clinical development: 42% two-year overall survival and ~21-month median overall survival in heavily pretreated microsatellite stable (MSS) metastatic CRC (mCRC) patients BATTMAN Phase 3 registrational trial underway: First global next-generation CTLA-4/PD-1 combination registrational trial in refractory MSS mCRC France expands reimbursed AAC access: Metastatic ovarian cancer and sarcoma added alongside MSS mCRC Zydus collaboration strengthens balance sheet and manufacturing capacity: Strategic capital and dedicated U.S. biologics p

    3/16/26 7:30:00 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $AULT
    $AUVI
    $BCEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by LQR House Inc.

    SC 13D/A - LQR House Inc. (0001843165) (Subject)

    11/25/24 4:41:10 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Agenus Inc.

    SC 13G/A - AGENUS INC (0001098972) (Subject)

    11/14/24 7:58:18 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Virax Biolabs Group Limited

    SC 13G/A - Virax Biolabs Group Ltd (0001885827) (Subject)

    11/14/24 4:46:07 PM ET
    $VRAX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care